Wire · operational-macro
FDA Approves Weekly Insulin for Pediatric Type 2 Diabetes
◆ Sectors
Medtech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 20 November 2026 · Fusion42 review
The FDA approved once-weekly insulin icodec-abae (Awiqli) for pediatric patients aged 10 and above with type 2 diabetes, providing an alternative to daily basal insulin injections with a safety profile consistent with existing insulin products.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
This FDA approval opens the door for you to pitch a weekly insulin product as a simpler paediatric diabetes treatment, challenging daily insulin makers and shifting patient adherence expectations.
◆ Coverage
1 source · 20 Nov 2026
◆ Related on Wire
◆ Topics
Medtechinsulinpediatricstype-2-diabetesfda-approvalweekly-injection